Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AVTXAvalo Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $59.00K |
| Revenue, yoy | −86.6% |
| Net income | $78.26M |
| Net income, yoy | −122.8% |
| Net margin | -132,642.4% |
| Free cash flow | $26.85M |
| FCF margin | — |
| EPS, diluted | $5.84 |
Add another company.